CXCR4 and pancreatic neoplasm: Moreover, C-X-C motif chemokine receptors also contribute to Gemcitabine resistance, and combination with a CXCR4 antagonist (AMD3100) or hedgehog inhibitor (GDC-0449) with gemcitabine inhibit the growth of orthotopic pancreatic tumor-bearing mice [63].